Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.
Vaccine
; 35(45): 6218-6227, 2017 10 27.
Article
in En
| MEDLINE
| ID: mdl-28947345
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasmodium falciparum
/
Protozoan Proteins
/
Adjuvants, Immunologic
/
Malaria Vaccines
/
Immunogenicity, Vaccine
/
Membrane Proteins
/
Antigens, Protozoan
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Africa
/
Europa
Language:
En
Journal:
Vaccine
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: